China has warned it is "not afraid" of a trade war with the United States, calling instead for dialogue grounded in "equa ...

Barclays lowered the firm’s price target on Johnson & Johnson to $165 from $166 and keeps an Equal Weight rating on the shares following ...

Johnson & Johnson is increasing its dividend for the 63rd consecutive year. This further cements the healthcare giant's ...

The company posted adjusted earnings of $2.77 per share on revenue of $21.9 billion, exceeding consensus estimates of $2.59 ...

In the US, healthcare costs and prices have been increasing. According to the Centers for Medicare & Medicaid Services, U.S.